We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$9.62B
AUM Growth
+$9.12B
Cap. Flow
+$10.4B
Cap. Flow %
107.78%
Top 10 Hldgs %
35.81%
Holding
968
New
940
Increased
2
Reduced
1
Closed

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Financials 20.93%
3 Industrials 11.05%
4 Healthcare 9.88%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRCA
576
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
$2.51M 0.03%
+256,126
New +$2.51M
IAA
577
DELISTED
IAA, Inc. Common Stock
IAA
$2.5M 0.03%
+76,442
New +$2.8M
BCRX icon
578
BioCryst Pharmaceuticals
BCRX
$2.37B
$2.5M 0.03%
+236,327
New +$2.44M
PSPC
579
DELISTED
Post Holdings Partnering Corporation
PSPC
$2.5M 0.03%
+257,374
New +$2.5M
HCII
580
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$2.49M 0.03%
+253,262
New +$2.48M
ALCE
581
DELISTED
Alternus Clean Energy Inc
ALCE
$2.48M 0.03%
+10,112
New +$2.49M
BSLK
582
DELISTED
Bolt Projects Holdings
BSLK
$2.48M 0.03%
+12,694
New +$2.48M
WPCA
583
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$2.48M 0.03%
+252,785
New +$2.48M
PICC
584
DELISTED
Pivotal Investment Corporation III
PICC
$2.48M 0.03%
+252,788
New +$2.48M
MTAL
585
DELISTED
Metals Acquisition
MTAL
$2.48M 0.03%
+252,788
New +$2.5M
VNET
586
VNET Group
VNET
$2.03B
$2.46M 0.03%
+407,919
New +$2.42M
FOUN
587
DELISTED
Founder SPAC Class A Ordinary Shares
FOUN
$2.43M 0.03%
+241,829
New +$2.43M
RVNC
588
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.42M 0.03%
+175,179
New +$2.7M
DE icon
589
Deere & Co
DE
$168B
$2.41M 0.03%
+8,058
New +$2.97M
LEAP
590
DELISTED
Ribbit LEAP, Ltd.
LEAP
$2.36M 0.02%
+238,370
New +$2.36M
FNVT
591
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.35M 0.02%
+236,261
New +$2.35M
DNAD
592
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.33M 0.02%
+239,964
New +$2.33M
CITE
593
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.32M 0.02%
+231,637
New +$2.32M
BAX icon
594
Baxter International
BAX
$14.1B
$2.31M 0.02%
+36,038
New +$2.62M
PBF icon
595
PBF Energy
PBF
$7.12B
$2.29M 0.02%
+78,963
New +$2.47M
IONS icon
596
Ionis Pharmaceuticals
IONS
$9.13B
$2.28M 0.02%
+61,497
New +$2.32M
MRSN
597
DELISTED
Mersana Therapeutics
MRSN
$2.27M 0.02%
+19,642
New +$1.85M
PLTR icon
598
Palantir
PLTR
$409B
$2.27M 0.02%
+250,000
New +$2.47M
SILK
599
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$2.25M 0.02%
+61,730
New +$2.24M
NUVA
600
DELISTED
NuVasive, Inc.
NUVA
$2.23M 0.02%
+45,407
New +$2.44M

Similar funds

UBS O'Connor's Q2 2022 Portfolio in Review

As of Q2 2022, UBS O'Connor held 968 positions worth $9.62B, up 1,838% from $496M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS O'Connor deployed $10.4B of net new capital in Q2 2022, opening 940 new positions and adding to 2 existing holdings. Its largest new stake was Rogers Corp: 1,780,443 shares worth $467M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 85% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was TEGNA Inc, an estimated $1.1M trimmed.

  • UBS O'Connor's largest Q2 2022 buy was Rogers Corp: 1,780,443 shares worth $467M.
  • UBS O'Connor added most to Activision Blizzard in Q2 2022, an estimated $107M increase.
  • UBS O'Connor's biggest Q2 2022 reduction was TEGNA Inc, cutting an estimated $1.1M.
  • UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
  • UBS O'Connor opened 940 new positions and closed 0 in Q2 2022.
  • UBS O'Connor's portfolio value rose 1,838% quarter-over-quarter to $9.62B.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.